1 |
Olson JD. D-dimer: an overview of hemostasis and fib-rinolysis, assays, and clinical application[J]. Adv Clin Chem, 2015 (69): 1-46.
|
2 |
Bates SM. D-Dimer assays in diagnosis and management of thrombotic and bleeding disorders[J]. Semin Thromb Hemost, 2012, 38 (7): 673-682.
|
3 |
Naess IA, Christiansen SC, Romudstad P, et al. Incidence and mortality of venous thrombosis: a population-based study[J]. J Thromb Haemost, 2007, 5 (4): 692-699.
|
4 |
Wibur J, Shian B. Diagnosis of deep venous thrombosis and pulmonary embolism[J]. Am Fam Physician, 2012, 86 (10): 913-919.
|
5 |
朱铁楠. D-二聚体检测在静脉血栓栓塞性疾病诊治中的应用[J]. 中华内科杂志,2012,51(3): 240-242.
|
6 |
Harper PL, Theakston E, Ahmed J, et al. D-dimer co-ncentration increases with age reducing the clinical value of the D-dimer assay in the elderly[J]. Intern Med J, 2007, 37 (9): 607-613.
|
7 |
White RH. The epidemiology of venous thromboembolism[J]. Circulation, 2003 (107): 4-8.
|
8 |
Madoiwa S. Plasminogen activation and regulation of fibrinolysis[J]. Nihon Rinsho, 2014, 72 (7): 1218-1223.
|
9 |
Adam SS, Key NS, Greenberg CS. D-dimer antigen: current concepts and future prospects[J]. Blood, 2009, 113 (13): 2878-2887.
|
10 |
崔金芳,韩雪娇,徐晓敏,等. D-二聚体与乳腺癌的关系[J/CD]. 中华乳腺病杂志(电子版),2019,13(2): 111-114.
|
11 |
Schouten HJ, Koek HL, Oudega R, et al. Validation of two age dependent D-dimer cut-off values for exclusion of deep vein thrombosis in suspected elderly patients in primary care: retrospective, cross sectional, diagnostic analysis[J]. BMJ, 2012 (344): e2985.
|
12 |
Nybo M, Hvas AM. Age-adjusted D-dimer cut-off in the diagnostic strategy for deep vein thrombosis: a systematic review[J]. Scand J Clin Lab Invest, 2017, 77 (8): 568-573.
|
13 |
Douma RA, Tan M, Schutgens RE, et al. Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded[J]. Haematologica, 2012, 97(10): 1507-1513.
|
14 |
Polo Friz H, Pasciuti L, Meloni DF, et al. A higher d-dimer threshold safely rules-out pulmonary embolism very elderly emergency department patients[J]. Thromb Res, 2014, 133 (3): 380-383.
|
15 |
Nwose EU. Whole blood viscosity assessment issues Ⅱ: prevalence in endothelial dysfunction and hypercoagulation[J]. N Am J Med Sci, 2010, 2 (6): 252-257.
|
16 |
Singh B, Parsaik AK, Agarwal D, et al. Diagnostic accuracy of pulmonary embolism rule-out criteria: a systematic review and meta-analysis[J]. Ann Emerg Med, 2012, 59 (6): 517-520.e4.
|
17 |
Courtney DM, Steinberg JM, McCormick JC. Prospective diagnostic accuracy assessment of the HemosIL HS D-dimer to exclude pulmonary embolism in emergency department patients[J]. Thromb Res, 2010, 125 (1): 79-83.
|
18 |
Golemi I, Salazar Adum JP, Tafur A, et al. Venous thromboembolism prophylaxis using the Caprini score[J]. Dis Mon, 2019, 65 (8): 249-298.
|
19 |
中华医学会外科学分会血管外科学组. 深静脉血栓形成的诊断和治疗指南(第三版)[J]. 中华普通外科杂志,2017,32(9): 807-812.
|
20 |
Legnani C, Palareti G, Cosmi B, et al. Different cut-off values of quantitative D-dimer methods to predict the risk of venous thromboembolism recurrence: a posthoc analysis of the PROLONG study[J]. Haematologica, 2008, 93 (6): 900-907.
|
21 |
Aspray TJ, Hill TR. Osteoporosis and the ageing skeleton[J]. Subcell Biochem, 2019 (91): 453-476.
|
22 |
Srivastava M, Deal C. Osteoporosis in elderly: prevention and treatment[J]. Clin Geriatr Med, 2002, 18 (3): 529-555.
|
23 |
越雷,孙浩林,李淳德. 骨质疏松性脊柱新鲜性压缩骨折中老年患者的凝血功能变化[J]. 中华创伤骨科杂志,2019,21(11): 973-977.
|
24 |
Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis[J]. Am J Obstet Gynecol, 2006, 194 (2 Suppl): S3-S11.
|
25 |
张立涛,张静梅,梁俊生. 老年人骨折后早期下肢深静脉血栓形成情况分析[J]. 中国骨质疏松杂志,2013,19(1): 43-45,82.
|
26 |
Rizzoli R, Reginster JY. Adverse drug reactions to osteoporosis treatments[J]. Expert Rev Clin Pharmacol, 2011, 4 (5): 593-604.
|
27 |
贾治国. 降钙素原和D-二聚体联合诊断骨质疏松的临床价值[J]. 国际检验医学杂志,2016,37(20): 2906-2908.
|
28 |
O'Brien JT, Thomas A. Vascular dementia[J]. Lancet, 2015, 386 (10004): 1698-1706.
|
29 |
Wolters FJ, Ikram MA. Epidemiology of vascular dementia[J]. Arterioscler Thromb Vasc Biol, 2019, 39(8): 1542-1549.
|
30 |
Kua EH, Ho E, Tan HH, et al. The natural history of dementia[J]. Psychogeriatrics, 2014, 14 (3): 196-201.
|
31 |
孙炎华,靳妮娜,张高星,等. 急性冠脉综合征预后与其支架术前CRP、Fib、D-二聚体水平的关系[J]. 心血管康复医学杂志,2013,22(2): 121-124.
|
32 |
Patil SM, Bankar MP, Padalkar RK, et al. Study of plasma fibrin D-dimer as maker of fibrinolysis and high sensitive C-reactive protein (hs-CRP) as potential inflammatory maker in acute stage of coronary heart disease[J]. JICC, 2014, 4 (1): 8-13.
|
33 |
Carcaillon L, Gaussem P, Ducimetière P, et al. Elevated plasma fibrin D-dimer as a risk factor for vascular dementia: the Three-City cohort study[J]. J Thromb Haemost, 2009, 7 (12): 1972-1978.
|
34 |
梁永志. 血清Hcy、D-D、hs-CRP水平变化与血管性痴呆患者认知功能的关联性及联合监测临床意义[J]. 药品评价,2020,17(5): 15-16,63.
|
35 |
Chao C, Huang G, Li X, et al. Change of glutamic acid decarboxylase antibody and protein tyrosine phosphatase antibody in Chinese patients with acuteonset type 1 diabetes mellitus[J]. Chin Med J (Engl), 2013, 126 (21): 4006-4012.
|
36 |
Domingueti CP, Dusse LM, Carvalho Md, et al. Diabetes mellitus: the linkage between oxidative stress, inflammation, hypercoagulability and vascular complications[J]. J Diabetes Complications, 2016, 30 (4): 738-745.
|
37 |
龙韵平. 2-型糖尿病患者血浆D-二聚体水平研究[J]. 当代医学,2015,21(10): 53,54.
|
38 |
王滋华. 血浆D-二聚体和纤维蛋白原检测在Ⅱ型糖尿病肾病患者中的临床应用[J/CD]. 临床检验杂志(电子版),2020,9(2): 113-114.
|
39 |
Khalil J, Bensaid B, Elkacemi H, et al. Venous thromboembolism in cancer patients: an underestimated major health problem[J]. World J Surg Oncol, 2015 (13): 204.
|
40 |
Sallah S, Wan JY, Nguyen NP. Venous thrombosis in patients with solid tumors: determination of frequency and characteristics[J]. Thromb Haemost, 2002, 87 (4): 575-579.
|
41 |
Handforth C, Clegg A, Young C, et al. The prevalence and outcomes of frailty in older cancer patients: a systematic review[J]. Ann Oncol, 2015, 26 (6): 1091-1101.
|
42 |
Lyman GH, Bohlke K, Khorana AA, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update 2014[J]. J Clin Oncol, 2015, 33 (6): 654-656.
|
43 |
Vitale C, D'Amato M, Calabrò P, et al. Venous thromboembolism and lung cancer: a review[J]. Multidiscip Respir Med, 2015, 10 (1): 28.
|
44 |
Heit JA, Silverstein MD, Mohr DN, et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study[J]. Arch Intern Med, 2000, 160 (6): 809-815.
|
45 |
Chew HK, Wun T, Harvey D, et al. Incidence of venous thromboembolism and its effect on survival among patients with common cancers[J]. Arch Intern Med, 2006, 166 (4): 458-464.
|
46 |
Sorensen HT, Mellemkjaer L, Olsen JH, et al. Prognosis of cancers associated with venous thromboembolism[J]. N Engl J Med, 2000, 343 (25): 1846-1850.
|
47 |
Knowlson L, Bacchu S, Paneesha S, et al. Elevated D-dimers are also a marker of underlying malignancy and increased mortality in the absence of venous thromboembolism[J]. J Clin Pathol, 2010, 63 (9): 818-822.
|
48 |
周贞. D-二聚体检测在妇科恶性肿瘤中的临床意义[J]. 中国卫生检验杂志,2010,20(5): 1141-1142.
|
49 |
樊炜静,张寅峰,严仕梦,等. 压力治疗在预防术后深静脉血栓形成中的应用[J]. 海南医学院学报,2020,26(14): 1116-1120.
|
50 |
Hanison E, Corbett K. Non-pharmacological interventions for the prevention of venous thromboembolism: a literature review[J]. Nurs Stand, 2016, 31 (8): 48-57.
|
51 |
Jacobs B, Henke PK. Evidence-based therapies for pharmacologic prevention and treatment of acute deep vein thrombosis and pulmonary embolism[J]. Surg Clin North Am, 2018, 98 (2): 239-253.
|
52 |
Uchino K. Review: low-molecular-weight heparin is better than unfractionated heparin to prevent VTE after ischemic stroke[J]. ACP J Club, 2008, 149 (1): 8.
|
53 |
黄冬琴,吴蔓. 不同剂量尿激酶经导管溶栓治疗下肢深静脉血栓形成的疗效[J]. 医学信息,2020,33(10): 122-123.
|
54 |
中国静脉介入联盟,中国医师协会介入医师分会外周血管介入专业委员会. 下肢深静脉血栓形成介入治疗护理规范专家共识[J]. 介入放射学杂志,2020,29(6): 531-540.
|
55 |
Bikdeli B, Chatterjee S, Desai NR, et al. Inferior vena cava filters to prevent pulmonary embolism: systematic review and meta-analysis[J]. J Am Coll Cardiol, 2017, 70 (13): 1587-1597.
|
56 |
董国祥. 下肢深静脉血栓形成的手术取栓术[J]. 中国实用外科杂志,2001,21(5): 312-313.
|